[go: up one dir, main page]

DE60323088D1 - Leberschützende wirkung der 10-o-p-hydroxybenzoylaucubin - Google Patents

Leberschützende wirkung der 10-o-p-hydroxybenzoylaucubin

Info

Publication number
DE60323088D1
DE60323088D1 DE60323088T DE60323088T DE60323088D1 DE 60323088 D1 DE60323088 D1 DE 60323088D1 DE 60323088 T DE60323088 T DE 60323088T DE 60323088 T DE60323088 T DE 60323088T DE 60323088 D1 DE60323088 D1 DE 60323088D1
Authority
DE
Germany
Prior art keywords
hydroxybenzoylaucubine
vaccinating
effect
vaccinating effect
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60323088T
Other languages
English (en)
Inventor
Anil Prabhakar
Bishan Datt Gupta
Krishan Avtar Suri
Naresh Kumar Satti
Swadesh Malhotra
Rakesh Kamal Johri
Bupinder Singh Jaggi
Bal Krishan Chandan
Ashok Kumar Sharma
Devinder Kumar Gupta
Bal Krishan Kapahi
Kasturi Lal Bedi
Om Parkash Suri
Gulam Nabi Qazi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Council of Scientific and Industrial Research CSIR
Original Assignee
Council of Scientific and Industrial Research CSIR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Council of Scientific and Industrial Research CSIR filed Critical Council of Scientific and Industrial Research CSIR
Application granted granted Critical
Publication of DE60323088D1 publication Critical patent/DE60323088D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Transplantation (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
DE60323088T 2002-05-10 2003-05-09 Leberschützende wirkung der 10-o-p-hydroxybenzoylaucubin Expired - Lifetime DE60323088D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39735902P 2002-05-10 2002-05-10
PCT/IB2003/001810 WO2003094911A1 (en) 2002-05-10 2003-05-09 Hepatoprotective activity of 10-o-p-hydroxybenzoyiaucubin

Publications (1)

Publication Number Publication Date
DE60323088D1 true DE60323088D1 (de) 2008-10-02

Family

ID=29420657

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60323088T Expired - Lifetime DE60323088D1 (de) 2002-05-10 2003-05-09 Leberschützende wirkung der 10-o-p-hydroxybenzoylaucubin

Country Status (8)

Country Link
US (1) US20040029816A1 (de)
EP (1) EP1509223B1 (de)
JP (1) JP4596911B2 (de)
CN (1) CN100512811C (de)
AU (1) AU2003230064A1 (de)
DE (1) DE60323088D1 (de)
WO (1) WO2003094911A1 (de)
ZA (1) ZA200409049B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA024466B1 (ru) * 2012-06-07 2016-09-30 Михаил Александрович ГЕТЬМАН Гепатопротекторное средство
KR102192768B1 (ko) * 2018-12-07 2020-12-18 전북대학교산학협력단 식나무 추출물을 포함하는 황반변성의 예방 또는 치료용 약학적 조성물
KR102727828B1 (ko) * 2022-08-30 2024-11-08 국립순천대학교산학협력단 신규한 바이텍스 비 화합물 및 이를 포함하는 항염증용 조성물
KR102727830B1 (ko) * 2022-08-30 2024-11-08 국립순천대학교산학협력단 신규한 바이텍스 씨 화합물 및 이를 포함하는 항염증용 조성물

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6037999A (ja) * 1983-08-09 1985-02-27 Osaka Chem Lab 肝障害有効薬物の簡易試験法
US5272172A (en) * 1990-10-09 1993-12-21 Tsumura & Co. Iridoid derivatives and the use thereof as a drug
US5145955A (en) * 1991-10-28 1992-09-08 Council Of Scientific & Industrial Research Process for the preparation and composition of a fraction containing picroside I and kutkoside
KR100218052B1 (ko) * 1992-07-15 1999-09-01 이병언 B형 간염 바이러스의 복제를 억제하는 약학적 제제
CN1200290A (zh) * 1997-05-24 1998-12-02 汪怀元 一种治疗肝病的药方
CN1258545A (zh) * 1998-12-28 2000-07-05 文天成 药制保健竹凉席及其制作方法
US6242012B1 (en) * 1999-10-19 2001-06-05 Thomas Newmark Herbal composition for promoting hormonal balance in women and methods of using same
CN1086300C (zh) * 1999-11-05 2002-06-19 汪怀元 一种治疗肝病的药物

Also Published As

Publication number Publication date
WO2003094911B1 (en) 2003-12-31
EP1509223A1 (de) 2005-03-02
JP2005530767A (ja) 2005-10-13
WO2003094911A1 (en) 2003-11-20
US20040029816A1 (en) 2004-02-12
ZA200409049B (en) 2005-11-30
CN1658865A (zh) 2005-08-24
EP1509223B1 (de) 2008-08-20
CN100512811C (zh) 2009-07-15
AU2003230064A1 (en) 2003-11-11
JP4596911B2 (ja) 2010-12-15

Similar Documents

Publication Publication Date Title
DK3536344T3 (da) Superfin formoterolformulering
NO20050132D0 (no) Vaksinesammensetning
DE60318132D1 (de) Haarwaschmittel
ATE477757T1 (de) Intramedullärer marknagel
NO20044046L (no) Substituerte hydroksyetylaminer
DE60329874D1 (de) Haarwaschmittel
DE60319547D1 (de) Haarwaschmittel
IS7831A (is) Bóluefni
IS8325A (is) Bóluefni
PT1393641E (pt) Entretela fixante
ATE496887T1 (de) Substituierte 5-aminomethyl-1h-pyrrol-2-carbons ureamide
DE60328408D1 (de) Impfstoff
DE60324491D1 (de) Kultivator
DE60315984D1 (de) Substituierte benzisoxazolsulfonamide mit breitbändiger hiv-protease hemmender wirkung
DE60335978D1 (de) Haarwaschmittel
NO20043664L (no) Ny fremgangsmate
DE60323088D1 (de) Leberschützende wirkung der 10-o-p-hydroxybenzoylaucubin
NO20051561D0 (no) Vaksine
DE50309824D1 (de) Bodenbearbeitungsgerät
DE60320425D1 (de) Ostertagia-impfstoff
FR2839258B1 (fr) Deambulateur-siege
DE50306228D1 (de) Substituierte benzdioxepine
ITRE20020026A1 (it) Zanzariera
FI20020094A (fi) Nefriinintapaisten yhdisteiden käyttö
SE0202239D0 (sv) Novel use

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
R082 Change of representative

Ref document number: 1509223

Country of ref document: EP

Representative=s name: BOEHMERT & BOEHMERT, DE